India's Significant Contributions to Global Healthcare Through Pharmaceutical Exports
India, a key player in the global pharmaceutical sector, significantly contributes to global health through its pharmaceutical exports. The country provides generic medicines to over 200 countries, with a notable presence in highly regulated markets. India's pharmaceutical exports showcase impressive growth rates, with a substantial portion of WHO pre-qualified APIs and vaccine requirements sourced from the country. Indian pharmaceutical companies have achieved numerous regulatory approvals, cementing their position as major players in the global market.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
E N D
Presentation Transcript
Pharmaceuticals Export Council of India (Set up by Ministry of Commerce and Industry, Govt. of India) India s Pharma Exports Contribution to Global Health 1
Indias Pharma Credentials India provides generic medicines to more than 200 countries. 8 out of 20 Global Generic companies are from India Over 55% Exports to Highly Regulated Markets 90% of WHO Pre-Qualified API s are sourced from India 65-70% of WHO s vaccine requirements are sourced from India No.of USFDA approved sites: 741 (as of Aug 2021) No of Sites with Registered with EU GMP 743 (as on Dec 2021) No.of ANDA Market Authorizations secured by Indian companies: 4346 (as on Dec 2020) 2
Pharma Exports Exports in FY-21 $ 24.5 bn (18.2% Gr) Exports (BN $) 30 Exports during Apr-Dec 2021-22 $ 18.22 bn (0.80% Gr) 24.5 25 20.7 19.13 20 77% 17.27 16.89 16.78 15.4 14.93 15 & Formulations 10 Growth Rate Biologicals 18% 3.14% 9.67% -0.65% 2.92% 10.72% 8.2% 18.2% 5 2.8% 2.2% API & 0 Intermediates Ayush & Herbal Products FY 14 FY 15 FY 16 Fy 17 FY 18 FY 19 FY 20 FY-21 Surgicals 3
Region wise Pharma Exports Others 1% Oceania 2% Asia (Excl Middle East) 4% CIS South Asia 4% TOP 10 EXPORT DESTINATIONS North America 33% Middle East 6% Exports (mn USD) Asean 6% 7723.55 U S A SOUTH AFRICA 833.6 LAC 6% U K 716.97 RUSSIA 590.8 EU 15% Africa 18% GERMANY 576.39 NIGERIA 573.22 BRAZIL 525.57 CANADA 441.77 FRANCE 413.1 CHINA P RP 382.73 0 1000 2000 3000 4000 5000 6000 7000 8000 3
Indias Contribution to the Suffering Mankind Indian made generic version of Sivoldi (Sofosbuvir) tablet, has reduced the cost of an Australian Hepatitis C patient from 10,000 AUD to 900 AUD for the treatment regime of 84 tablets'. (Times of India on 30 Aug 2015) Veenat, India-produced generic version of Glivec (Imatinib Mesylate Tablets) has reduced the cost of a Chinese CML patient from $3783 to $30 for a month s dosage . (Global Times in Jan 2015 ) Medicine Sans Frontiers Purchases 80% of its ARVs from India The United Nations Children s Fund (UNICEF) Bill & Melinda Gates Foundation The Global Fund and The Clinton Foundation Partnersh ip with Global NGOs Indian Generic ARVs approved by the USFDA also resulted in cost-savings over 90% of the ARVs for PEPFAR PEPFA R Major source of supplier of Essential vaccines & Pre qualified APIs WHO 7
Pandemic Response by India Medication: All the products which have been approved for treatment of COVID comes with made in India Label Remdesivir, Favipiravir, Molunipiravir etc Covid vaccines: 115 million doses of Covid Vaccines are already supplied to more than 97 countries under Vaccine Maitri Bharath Biotech: Developed COVAXIN in collaboration with ICMR and NIV Serum Institute of India : COVISHIELD . Partnership with Gavi, the vaccine Alliance and Bill & Melinda Gates Foundation for 100 million doses Novavax sVaccine Covovax Zydus Cadila: Developed world first DNA based Covid vaccine (ZyCov-D)- Needleless vaccine Collaboration for Sputnik-V: Agreements with Russian Direct Investment Fund (RDIF) Biological E: Development & manufacture of Corbevax & Collaboration for manufacturing Jhonson & Jhonson vaccine 8
